Residents and Fellows
Contribute to EyeWiki by 11:59 PM PST, Nov. 30, 2024, for a chance to attend the Academy’s Mid-Year Forum 2025.
If you are an ophthalmology resident or fellow in training in the United States, the American Academy of Ophthalmology encourages you to take advantage of the phenomenal online publishing opportunity EyeWiki provides. Qualifying entries will be considered for one of four all-expenses-paid trips to the Academy’s Mid-Year Forum 2025 in Washington, DC, in April. Expenses will be covered for travel within the United States and U.S. territories.
During the contest period, write an original article that covers a topic not currently included in EyeWiki or update and revise an existing article. To enter the contest, first register for an EyeWiki account. Your EyeWiki account must be approved before you can make contributions; please allow up to 36 hours for account approval.
After creating or revising an article, use the “Enroll in the Residents and Fellows contest” submission button on the article page to submit it for the competition.
Rules and Restrictions
All Submissions:
- Entrants must be ophthalmology residents or fellows in training in the United States, with a valid EyeWiki account.
- Only original articles written and revisions made between December 1, 2023 and 11:59 PM PST, Nov. 30, 2024, as logged in the article's history page and matching the entrant's username will be considered.
- Entrants may submit as many articles and revisions as they like.
- Contestants are highly encouraged to consider revising an article instead of submitting a new article. New articles that duplicate or significantly overlap existing articles will not be considered.
- Because EyeWiki articles are subject to revision at any time by any ophthalmologist with an EyeWiki account, the same article may be submitted by more than one entrant and to multiple contests.
- Example: Dr. A, a U.S. Resident, submits an original article to the U.S. Residents and Fellows Contest. Dr. B, who is also a U.S. resident, revises the article submitted by Dr. A, and submits it to the U.S. Residents and Fellows contest. Dr. C, an international ophthalmologist revises the original article by Dr. A, and submits the article to the International Contest.
- To see all contest entries for an article, click “Contest entries for this page.”
- EyeWiki editors are not eligible to participate in EyeWiki contests.
Revised Articles:
- Eligible articles are those which have been reviewed at least once by an EyeWiki section editor. Check the name in the “Reviewed by” field, which should display a section editor’s name.
- Only the contributor who makes the revisions to the article and submits it to the contest will be considered for an award.
- At least 25% of the article text should be improved and references updated for the purpose of clarifying and/or updating the original information in the article. The addition of media--images, videos, or other rich content--is highly encouraged.
- Revisions must be made within the contest period.
Original Articles:
- To be considered for the contest, you must be the primary author of your article and it must be wholly original work. Only the primary author of the article, who submits it into the contest, will be considered for an award.
- Articles that significantly overlap or duplicate an existing article will not be considered.
- Articles must be written within the contest period.
Submission Criteria:
- The value of revisions to an existing article for the purpose of clarifying and/or updating the information
- The relevancy and relative importance of any new article submission
- Accuracy, currency, and completeness of the content
- Quality of the writing and organization
- Inclusion or updating of references
- Use of EyeWiki formatting: Layout, placement of media (images or video), hyperlinks, and heading styles where appropriate
- Check out this article as an example: Retinal Vasculitis.
Questions? Send an e-mail to eyewiki@aao.org.
Here is the list of current entries. Past entries and winners can be found on the discussion page.